First National Bank of Hutchinson’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,674
Closed -$227K 95
2023
Q3
$227K Buy
1,674
+25
+2% +$3.42K 0.17% 97
2023
Q2
$236K Buy
1,649
+101
+7% +$14.9K 0.17% 99
2023
Q1
$215K Buy
1,548
+16
+1% +$2.15K 0.17% 100
2022
Q4
$208K Buy
+1,532
New +$192K 0.18% 104

Other funds holding AZN

First National Bank of Hutchinson's AZN Position: Q4 2023 in Review

First National Bank of Hutchinson sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 1,674 shares — an estimated $227K sold.

First National Bank of Hutchinson first reported a position in AZN in Q4 2022 and held it in 4 quarters. The position peaked at $236K in Q2 2023. 1,131 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • First National Bank of Hutchinson reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
  • First National Bank of Hutchinson sold 1,674 AstraZeneca shares in Q4 2023, an estimated $227K.
  • First National Bank of Hutchinson first reported a position in AstraZeneca in Q4 2022 and held it in 4 quarters.
  • First National Bank of Hutchinson's AstraZeneca position peaked at $236K in Q2 2023.
  • 1,131 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on First National Bank of Hutchinson's 13F filing for Q4 2023, filed 25 Jan 2024.